Global Market for Women’s Health Devices Sees Moderate Growth
By HospiMedica International staff writers Posted on 29 Nov 2015 |
The global market for women’s health devices is forecast to grow from an estimated USD 1.8 billion in 2014 to approximately USD 2.4 billion in 2021, representing a compound annual growth rate of 3.7%. These are the latest findings of GlobalData (London, United Kingdom), an international business intelligence provider.
The market encompasses treatments for conditions that are particular to the adult female anatomy; this includes abnormal uterine conditions, such as menorrhagia and uterine fibroids, pelvic disorders such as female stress urinary incontinence, and anti-conceptive procedures. Minimally invasive technologies to treat these conditions as alternatives to conventional surgery are expected to see increased adoption in the coming years, due to increased physician and patient awareness and an increasing number of women proactively seeking treatment.
Technologies include endometrial resection devices, uterine fibroid embolization agents, female sterilization devices, and female urinary incontinence slings. As more women seek treatment for uterine health and incontinence issues, the market will become increasingly competitive, provided that the new technology meets efficacy and safety standards. However, recent lawsuits related to safety issues with some of these devices have received widespread media attention, particularly in the urinary incontinence sling market, causing some skepticism.
“The understanding that a woman’s quality of life can be vastly improved by new technologies coincides with the awareness that a variety of new treatment options, such as global endometrial ablation and uterine artery embolization, are far less invasive than surgery,” said GlobalData analyst Premdharan Meyyan. “For women who suffer from abnormal uterine conditions, such as heavy menstrual bleeding and uterine fibroids, these new technologies offer safe and effective alternative treatment options to patients who do not wish to undergo invasive surgery.”
Related Links:
GlobalData
The market encompasses treatments for conditions that are particular to the adult female anatomy; this includes abnormal uterine conditions, such as menorrhagia and uterine fibroids, pelvic disorders such as female stress urinary incontinence, and anti-conceptive procedures. Minimally invasive technologies to treat these conditions as alternatives to conventional surgery are expected to see increased adoption in the coming years, due to increased physician and patient awareness and an increasing number of women proactively seeking treatment.
Technologies include endometrial resection devices, uterine fibroid embolization agents, female sterilization devices, and female urinary incontinence slings. As more women seek treatment for uterine health and incontinence issues, the market will become increasingly competitive, provided that the new technology meets efficacy and safety standards. However, recent lawsuits related to safety issues with some of these devices have received widespread media attention, particularly in the urinary incontinence sling market, causing some skepticism.
“The understanding that a woman’s quality of life can be vastly improved by new technologies coincides with the awareness that a variety of new treatment options, such as global endometrial ablation and uterine artery embolization, are far less invasive than surgery,” said GlobalData analyst Premdharan Meyyan. “For women who suffer from abnormal uterine conditions, such as heavy menstrual bleeding and uterine fibroids, these new technologies offer safe and effective alternative treatment options to patients who do not wish to undergo invasive surgery.”
Related Links:
GlobalData
Latest Business News
- Johnson & Johnson Acquires Cardiovascular Medical Device Company Shockwave Medical
- Mindray to Acquire Chinese Medical Device Company APT Medical
- Olympus Acquires Korean GI Stent Maker Taewoong Medical
- Karl Storz Acquires British AI Specialist Innersight Labs
- Stryker to Acquire French Joint Replacement Company SERF SAS
- Medical Illumination Acquires Surgical Lighting Specialist Isolux
- 5G Remote-Controlled Robots to Enable Even Cross-Border Surgeries
- International Hospital Federation Announces 2023 IHF Award Winners
- Unprecedented AI Integration Transforming Surgery Landscape, Say Experts
- New WHO Guidelines to Revolutionize AI in Healthcare
- Getinge Acquires US-Based Medical Equipment Provider Healthmark Industries
- Global Surgical Lights Market Driven by Increasing Number of Procedures
- Global Capsule Endoscopy Market Driven by Demand for Accurate Diagnosis of Gastrointestinal Conditions
- Global OR Integration Market Driven by Need for Improved Workflow Efficiency and Productivity
- Global Endoscopy Devices Market Driven by Increasing Adoption of Endoscopes in Surgical Procedures
- Global Minimally Invasive Medical Devices Market Driven by Benefits of MIS Procedures